Go Pro

NRx Pharmaceuticals (NRXP) Institutional Ownership

NRx Pharmaceuticals logo
$3.92 -0.24 (-5.77%)
Closing price 04:00 PM Eastern
Extended Trading
$3.95 +0.03 (+0.77%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)

Current
Institutional Ownership
Percentage
4.27%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$6.76M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$294.87K
Get NRXP Insider Trade Alerts

Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NRXP Institutional Buying and Selling by Quarter

NRx Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/5/2026Ethos Financial Group LLC15,900$34K0.0%+33.6%0.048%
4/28/2026AdvisorShares Investments LLC420,467$896K0.2%+28.2%1.271%
2/17/2026Anson Funds Management LP3,043,957$8.25M0.8%+50.3%10.284%
2/13/2026State Street Corp86,984$236K0.0%+14.0%0.294%
2/12/2026Commonwealth Equity Services LLC366,631$994K0.0%N/A1.238%
2/10/2026AdvisorShares Investments LLC328,004$889K0.1%-4.1%1.108%
2/9/2026Geode Capital Management LLC218,866$593K0.0%+17.8%0.739%
2/9/2026Bleakley Financial Group LLC117,204$318K0.0%N/A0.396%
2/6/2026Global Retirement Partners LLC39,300$107K0.0%N/A0.133%
1/14/2026Sjbenen Advisory LLC15,000$41K0.0%N/A0.051%
1/14/2026One Wealth Management Investment & Advisory Services LLC37,873$103K0.1%+35.3%0.128%
11/17/2025Anson Funds Management LP2,025,104$6.68M0.6%+26.2%10.223%
11/14/2025Two Sigma Investments LP52,332$173K0.0%+66.4%0.264%
11/7/2025Vanguard Group Inc.534,956$1.77M0.0%+18.3%2.700%
11/5/2025AdvisorShares Investments LLC342,136$1.13M0.2%+29.7%1.727%
10/29/2025One Wealth Management Investment & Advisory Services LLC27,991$92K0.1%+86.1%0.141%
10/23/2025Ethos Financial Group LLC11,900$39K0.0%N/A0.060%
8/13/2025Marshall Wace LLP33,384$109K0.0%-62.5%0.193%
8/8/2025Geode Capital Management LLC172,255$562K0.0%+27.9%0.996%
8/4/2025AdvisorShares Investments LLC263,797$860K0.2%-8.0%1.526%
5/28/2025Anson Funds Management LP1,179,061$2.42M0.4%+535.1%6.820%
5/14/2025Anson Funds Management LP1,179,061$2.42M0.3%+535.1%6.845%
2/17/2025Squarepoint Ops LLC25,299$56K0.0%N/A0.161%
2/17/2025Millennium Management LLC27,624$61K0.0%N/A0.176%
2/17/2025Anson Funds Management LP185,660$408K0.0%+30.3%1.183%
2/14/2025AdvisorShares Investments LLC310,314$683K0.1%+138.5%1.977%
2/14/2025Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096%
11/15/2024Anson Funds Management LP142,525$241K0.0%N/A1.326%
11/13/2024Townsquare Capital LLC15,041$25K0.0%N/A0.140%
8/8/2024AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010%
8/6/2024One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141%
2/14/2024AdvisorShares Investments LLC642,632$296K0.1%N/A0.755%
1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165%
11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398%
5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065%
2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086%
1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044%
1/27/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%
1/18/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%
11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094%
We were the only ones who warned you … (Ad)

During the Great Financial Crisis, one firm accurately predicted 464 of 465 bank failures before they happened - flagging Citigroup before its shares fell 90%, Washington Mutual before the second-largest bankruptcy in U.S. history, and Lehman Brothers six months before its collapse. That same system has averaged 310% gains on every 'buy' signal over the past two decades, including 9,822% on Monolithic Power Systems and 15,088% on Constellation Software. Now you can receive these early warnings before the market opens.tc pixel

Join the early warning list and get your first alert tomorrow morning
5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023%
4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027%


NRXP Institutional Ownership - Frequently Asked Questions

During the previous two years, 17 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were Anson Funds Management LP ($8.25M), Vanguard Group Inc. ($1.77M), Commonwealth Equity Services LLC ($994K), AdvisorShares Investments LLC ($896K), Geode Capital Management LLC ($593K), Bleakley Financial Group LLC ($318K), and State Street Corp ($236K).Learn more on NRx Pharmaceuticals' institutional investors.

4.27% of NRx Pharmaceuticals' stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings.

Of the 16 institutional investors that purchased NRx Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($3.61M), Commonwealth Equity Services LLC ($366.63K), AdvisorShares Investments LLC ($351.03K), Bleakley Financial Group LLC ($117.20K), Vanguard Group Inc. ($82.78K), Geode Capital Management LLC ($70.60K), and Global Retirement Partners LLC ($39.30K).

Institutional investors have bought a total of 2,371,614 shares in the last 24 months. This purchase volume represents approximately $6.76M in transactions.

The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: Marshall Wace LLP ($55.70K), and AdvisorShares Investments LLC ($37.13K).

Institutional investors have sold a total of 92,834 shares in the last 24 months. This volume of shares sold represents approximately $294.87K in transactions.



This page (NASDAQ:NRXP) was last updated on 7/8/2026 by MarketBeat.com Staff.
From Our Partners